1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow MM-111: new trials by email Literature Review of MM-111 trials Research Report on MM-111
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach MM-111, Paclitaxel, Trastuzumab - HER-2 Gene Amplification, Esophagus Cancer | Phase 2 | Terminated | Merrimack Pharmaceuticals | 84 | 2013-01-01 | 2017-06-22 |
Esophageal Neoplasms (1) · Neoplasm Metastasis (1) · Stomach Neoplasms (1)
United States (1)